FDA Inspection 1251233 — RPI Biosolutions
The FDA completed an inspection of RPI Biosolutions on Aug 21, 2024 in Mundelein, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Mundelein, IL (United States)